Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I am not convinced

This is about business, about maximumizing (sic) and monetizing the assets of which TPL/Moore themselves also own an equal interest; if that is at the expense or detriment of PTSC, it's Shareholders or it's "legacy", so be it

One has to wonder who might be the beneficiaries in the above stated scenario, price manipulators?, TPL?, Leckrone?, whom?

Unless Falk Jr has some perverse desire to see his assets decrease, I humbly suggest that he, along with all shareholders, have the same objective: an increasing share price.

.

.

.

Be well

Share
New Message
Please login to post a reply